Chronic heart failure is one of the most frequent causes of death in humans. Knockout of type 5 adenylyl cyclase (AC) in mice causes longevity and protection from cardiomyopathy, and an AC5 inhibitor reduces ␤-adrenoceptor-stimulated Ca 2ϩ inward currents in isolated mouse cardiomyocytes. These data indicate that selective AC5 inhibitors may be beneficial in chronic heart failure. Therefore, we characterized AC in mouse heart membranes. Real-time polymerase chain reaction and immunoblot analysis suggested that AC5 is an important heart AC isoform. Enzyme kinetics of heart AC and recombinant AC5 in the presence of Mg 2ϩ were similar. Moreover, the inhibitory profile of eight 2Ј(3Ј)-O-(N-methylanthraniloyl) (MANT)-nucleoside 5Ј-([␥-thio])triphosphates on mouse heart in the presence of Mg 2ϩ was almost identical to that of AC5. MANT-ITP was the most potent inhibitor of heart AC and recombinant AC5, with K i values in the 15 to 25 nM range in the presence of Mg 2ϩ and in the 1 to 5 nM range in the presence of Mn 2ϩ . However, in the presence of Mn 2ϩ , we also noted differences between mouse heart AC and AC5 with respect to enzyme kinetics and forskolin analog effects. In conclusion, with regard to expression and kinetics and inhibition by MANT-nucleotides in the presence of Mg 2ϩ , AC5 is an important AC isoform in heart, with MANT-ITP being an excellent starting point for the design of AC5-selective inhibitors. Unfortunately, a limitation of our study is the fact that immunologically and biochemically, AC5 and AC6 are quite similar, although they have different roles in heart. Moreover, lack of antibody specificity and Mn 2ϩ masking AC5 effects were problems.
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In the human heart, the ␤ 1 -adrenoceptor-G s protein-AC system is the major physiological mechanism for acute modulation of contractility (Lohse et al., 2003) . Gene knockout studies confirmed the major significance of the ␤ 1 -adrenoceptor for the regulation of heart function in mouse as well (Rohrer et al., 1996; Devic et al., 2001) . Nine membranebound AC isoforms (AC1-AC9), producing the second messenger cAMP, have been cloned in mammals. Gene expression studies showed that AC5 is the major cardiac AC isoform (Defer et al., 2000; Sunahara and Taussig, 2002; Beazely and Watts, 2006) . The diterpene FS from Coleus forskohlii effectively activates ACs 1 to 8 but not AC9 (Sunahara and Taussig, 2002) . Moreover, FS and FS analogs differentially activate recombinant ACs 1, 2, and 5 expressed in Sf9 insect cells (Pinto et al., 2008) . This was not expected because the FS binding site is highly conserved among the various AC isoforms (Sunahara and Taussig, 2002) .
Chronic heart failure is one of the most important causes of death in humans (Fonarow, 2008) . In chronic heart failure, desensitization of the myocardial ␤ 1 -adrenoceptor occurs, reducing the positive inotropic effects of catecholamines. An inverse correlation between survival and activation of the sympathetic system has been observed in chronic heart failure patients. Thus, ␤ 1 -adrenoceptor desensitization can be interpreted as energy-saving adaptation, protecting against the detrimental consequences of excessive adrenergic drive (Lohse et al., 2003) . Accordingly, the standard long-term treatment of chronic heart failure includes ␤ 1 -adrenoceptor antagonists, considerably reducing morbidity and mortality (Lohse et al., 2003) .
In a pressure overload model based on thoracic aortic banding, AC5 knockout mice show a stable left ventricular ejection fraction, whereas the cardiac performance of wild-type mice is impaired (Okumura et al., 2003) . Most strikingly, compared with wild-type mice, AC5 knockout mice show a considerably increased life span and protection from aginginduced cardiomyopathy and oxidative stress (Yan et al., 2007) . In addition, the AC5 knockout protects mice against ␤ 1 -adrenoceptor-induced cardiomyocyte apoptosis (Iwatsubo et al., 2004) . However, AC regulation in the heart is much more complex. In particular, the overexpression of AC6 in the heart reduces left ventricular remodeling, preserves left ventricular function, and reduces mortality in a myocardial infarction model (Takahashi et al., 2006) . Thus, it seems that AC5 and AC6 play opposing roles in heart function.
MANT-nucleotides inhibit AC isoforms 1, 2, 5, and 6, with ACs 1, 5, and 6 being more sensitive to inhibition than AC2 (Gille et al., 2004) . In mouse ventricular cardiomyocytes, injection of the AC5 inhibitor MANT-GTP␥S via the patchclamp pipette effectively reduces isoproterenol-stimulated L-type Ca 2ϩ inward currents, whereas in myocytes from AC5 knockout mice, the residual Ca 2ϩ current is not further attenuated by MANT-GTP␥S (Rottlaender et al., 2007) . These data support the notion that AC5 is the major AC isoform mediating acute ␤-adrenergic stimulation in mouse heart.
Based on all of the above-mentioned findings, AC5 inhibitors should be explored as new candidates for chronic heart failure therapy. Therefore, as an essential step toward this very ambitious goal, the aim of our present study was to provide a detailed characterization of mouse heart AC in comparison with recombinant AC isoforms, specifically AC5, using MANT-nucleotides and FS analogs as pharmacological tools. For the preparation of crude mouse heart membranes, we used a membrane preparation protocol that had been shown previously to yield robust AC activities (Rohrer et al., 1996) . To our knowledge, this is the first comprehensive pharmacological characterization of AC with activators and inhibitors in a native membrane system. Figure 1 shows the structures of the MANT-nucleotides and FS analogs examined in this study. All nucleotides possess a MANT-group at the 2Ј(3Ј)-O-ribosyl function. The MANT-group spontaneously isomerizes between the 2Ј-and 3Ј-O-ribosyl function (Gille et al., 2004; Taha et al., 2009 ). We studied MANT-nucleotides with purine bases (guanine, adenine, or hypoxanthine) as well as nucleotides with pyrimidine bases (uracil or cytosine). Moreover, we studied nucleotides with a triphosphate chain and nucleotides with a thiophosphate at the ␥-position, with the thiophosphate introducing bulkiness into the molecule and resistance against degradation by nucleotidases (Eckstein, 1985) . Concerning FS derivatives, we studied FS and FS derivatives missing an OH function at the 1Ј-or 9Ј-position of the diterpene ring or the acetyl group at the 7Ј-position. We also examined the diterpene with the acetyl group at the 6Ј-instead at the 7Ј-position, also referred to as iso-FS. Finally, we examined FS analogs with bulky substituents at the 6Ј-position, i.e., visualized by enhanced chemiluminescence (Pierce Chemical, Rockford, IL) using peroxidase-coupled goat anti-rabbit IgG (1:1000; Santa Cruz Biotechnology, Inc.). Preparation of Mouse Heart Membranes. Female CD1 mice were housed in cages in a temperature-and light-controlled environment according to the German animal protection law. At the age of 8 weeks, mice were sacrificed by cervical dislocation, and hearts were removed, shock-frozen in liquid nitrogen, and stored at Ϫ80°C. Mouse heart membranes were prepared according to a previously described protocol, with minor modifications (Rohrer et al., 1996) . In brief, hearts were thawed and rinsed in ice-cold homogenization buffer containing 5 mM Tris-HCl, pH 7.4, and 5 mM EDTA. All membrane preparation steps were conducted at 4°C. Homogenization was performed in a buffer volume amounting to 20-fold the heart tissue weight. Hearts were cut into small pieces and then homogenized in a glass-glass homogenizer (Braun, Melsungen, Germany) at 1500 rpm, applying five series of five strokes each, with a 1-min cooling period between each series. Organ debris was removed by an 8-min centrifugation at 500g. The supernatant suspension was sedimented by a 30-min centrifugation at 40,000g. The resultant membrane pellet was washed in a buffer volume amounting to 60-fold the heart tissue weight and sedimented by a 30-min centrifugation at 40,000g. To remove residual endogenous ligands and nucleotides, this washing procedure was performed three times before the membranes were resuspended in assay buffer consisting of 50 mM triethanolamine and 1 mM EGTA, pH 7.4. Membranes were resuspended with syringes in the sequence 21 gauge, 25 gauge, 27 gauge and then shock-frozen in liquid nitrogen and stored at Ϫ80°C. To detect robust AC activity in heart membranes, it was essential to follow the protocol described above. Specifically, the use of the above-described buffers was critical. When hearts were homogenized in the standard buffer used for Sf9 cell homogenization (Houston et al., 2002; Gille et al., 2005) , no AC activity was recovered. The reason for the striking impact of buffer composition on AC activity yield in mouse heart membranes is unknown. From a practical point of view, it is crucial to precisely follow the membrane preparation as described above and the AC assays protocol as described below to obtain reproducible results.
AC Activity Assay. Assay tubes contained 10 l of FS analogs, MANT-nucleotides, or receptor ligands and 20 l of reaction mixture consisting of (final) 7 mM Mn 2ϩ or Mg 2ϩ , 10 M GTP, 10 M GTP␥S, 100 M cAMP, 0.4 mg/ml creatine kinase, 9 mM phosphocreatine, 100 M IBMX, 10 M isoproterenol, and, unless stated otherwise, 100 M FS. In experiments aiming at the assessment of GPCR ligand effects on AC activity, GTP␥S and FS were omitted from reaction mixtures. Tubes also contained 40 M ATP and 0.2 to 1.0 Ci of [␣- 32 P]ATP. Tubes were preincubated for 2 min at 30°C, and reactions were initiated by the addition of 20 l of membranes (20 g of protein/tube), yielding 20 mM triethanolamine and 0.4 mM EGTA, pH 7.4, as assay buffer. For determination of K m and V max values, ATP/Mn 2ϩ or ATP/Mg 2ϩ (10 M-2 mM) plus 7 mM free Mn 2ϩ or Mg 2ϩ were added. In experiments with FS analogs, the MnCl 2 concentrations were increased to 10 mM to match previous conditions (Pinto et al., 2008) . Moreover, in those studies, GTP␥S (10 M) was included in reaction mixtures. To ensure linear reaction progress, tubes were incubated for 10 min at 30°C. In experiments for the determination of inhibitor potencies on cardiac AC, incubation time was reduced to 1 to 2 min to avoid nucleotide degradation. Reactions were terminated by the addition of 20 l of 2.2 N HCl, and denatured protein was sedimented by a 1-min centrifugation at 12,000g. [ 32 P]cAMP was separated from [␣- 32 P]ATP by transferring the samples to columns containing 1.4 g of neutral alumina. [ 32 P]cAMP was eluted into 20-ml scintillation vials by adding 4 ml of 0.1 M ammonium acetate, pH 7.0. Blank values were ϳ0.02% of the total amount of [␣- 32 P]ATP added; substrate turnover was Ͻ3% of the total added [␣-32 P]ATP. Scintillation vials were filled up with 10 ml of doubledistilled water, and Č erenkov radiation was determined.
Miscellaneous. Protein was determined using the DC protein assay kit (Bio-Rad Laboratories). Data shown in Tables 2 to 5 
Results

Detection of AC Isoforms in Mouse
Heart by RealTime PCR and Immunoblot Analysis. To investigate the mRNA expression levels of AC isoforms in mouse heart, we reverse-transcribed mRNA and performed real-time PCR using isoform-specific primers (Table 1) . PCR products were detected for ACs 1, 3 to 7, and 9 (Fig. 2) . No PCR products were obtained for ACs 2 and 8. The threshold values were 22 cycles for ACs 5 and 6; 25 cycles for ACs 1, 3, and 4; and 27 cycles for AC9.
Next, we examined AC expression at the protein level. The AC5/6 antibody yielded bands at ϳ120 to 140 kDa in mouse heart membranes using recombinant AC5 as positive control (Fig. 3A) . Immunologically detected bands were diffuse, compatible with ACs being glycosylated (Beazely and Watts, 2006) . Sf9 membranes expressing AC3 were used as negative control and did not show an immunoreactive band. The difference in migration between recombinant AC5 and native cardiac AC5/6 may be due to differences in AC5 glycosylation between Sf9 insect cells and mouse heart. It is also possible that the antibody primarily detected AC6 in heart membranes.
Unfortunately, our substantial efforts to conduct a comprehensive analysis of AC isoform expression in heart membranes were not successful. First, except for the AC5/6 antibody, in our hands, the other antibodies examined did not display sufficient sensitivity and/or selectivity to obtain reliable information about AC isoform expression in heart membranes, using Sf9 membranes expressing the corresponding AC isoforms as standard. In pars pro toto, Fig. 3B illustrates this problem for AC1. In Sf9 cell membranes, AC1 is expressed very well as assessed by enzyme activity (Gille et al., 2004; Pinto et al., 2008) . Thus, we expected to obtain clear immunoreactive bands with the AC1 antibody. However, both in membranes from uninfected Sf9 cells and AC1-expressing Sf9 cells, bands in the 120-kDa region and in the 50-kDa region were detected, but we failed to reveal a unique band in the AC1-expressing membranes. The immunologically recognized bands in membranes from uninfected Sf9 cells were actually more intense than in AC1 virus-infected cells, probably reflecting that the expression of certain proteins in Sf9 cells is decreased as a result of virus infection (Pinto et al., 2008) . Real-time PCR experiments and stimulation experiments with Ca 2ϩ /calmodulin confirmed that the AC expressed in Sf9 cells infected with AC1 virus was actually AC1 (data not shown). In heart membranes, the AC1 antibody failed to detect a specific band as well (data not shown). Similar problems concerning the specificity of AC jpet.aspetjournals.org antibodies are already described to some extent in the literature (Defer et al., 2000; Liu et al., 2008 (Pinto et al., 2008) . FS robustly increased AC activity in mouse heart membranes ( Fig. 4A) . In the presence of Mn 2ϩ or Mg 2ϩ , the EC 50 values for FS and the relative maximal stimulatory effects of FS were similar (Table 2) . FS activated ACs in the order of potency AC1 Ͼ AC5 ϳ mouse heart AC Ͼ AC2 ( Fig.  4B ; Table 2 ). FS increased basal AC activity in Sf9 cell membranes expressing ACs 1 and 2 by ϳ2-to 5-fold, whereas in Sf9 cell membranes expressing AC5 and mouse heart membranes, FS increased AC activity by ϳ15-to 20-fold. Thus, using FS as probe, there is a similarity of heart membrane AC with AC5. As outlined below, the situation with FS analogs is different.
In mouse heart membranes, FS analogs activated AC in the order of potency BODIPY-FS Ͼ FS ϳ 6A7DA-FS Ͼ DMB-FS Ͼ 7DA-FS ϳ 9d-FS (Table 3 ). The order of efficacy was Table 3 also includes the pharmacological profile of FS analogs on recombinant AC5. Note that the pharmacological profile of FS analogs on mouse heart AC and AC5 was assessed in the presence of Mn 2ϩ . With respect to the EC 50 values of FS analogs, we observed a significant correlation between mouse heart and AC5. However, the slope of the correlation was considerably steeper than 1.00, which value would have reflected pharmacological identity of the ACs studied (Fig. 5A) . With respect to the efficacies of FS analogs, the correlation between mouse heart and AC5 was not significant (Fig. 5B) . These data indicate that under Mn 2ϩ conditions, AC isoforms other than AC5 contribute to total AC activity in mouse heart membranes.
Regulation of Mouse Heart AC by GTP␥S, GTP, and Receptor Ligands. The nonhydrolyzable GTP analog GTP␥S activates AC through stimulation of G s ␣ (Gilman, 1987) . In the presence of Mg 2ϩ , GTP␥S increased AC activity 4-fold, with an EC 50 value of 80 nM (data not shown). In the presence of GTP (10 M), the ␤-adrenoceptor agonist isoproterenol increased AC activity approximately 2-fold, with an EC 50 value of 12 nM (Fig. 6A) . Using a very similar heart membrane preparation as in the present study, Rohrer et al. (1996) showed that isoproterenol increased AC activity by 150% with 53 M GTP. Thus, our results correspond well with the previous data, but Rohrer et al. (1996) did not report the absolute AC activities. It had already been shown that in mouse heart, 72% of the ␤-adrenoceptors belong to the ␤ 1 -subtype, whereas 28% belong to the ␤ 2 -subtype (Rohrer et al., 1996) . In addition, studies with ␤ 1 -adrenoceptor knockout mice revealed that ϳ90% of the isoproterenol-stimulated AC activity is attributable to the ␤ 1 -adrenoceptor (Rohrer et al., 1996) . Figure 6B shows the concentration-response curves for the effects of GTP on AC activity. GTP effectively supported isoproterenol-stimulated AC activity; the EC 50 for GTP was 100 nM. GTP also exhibited a modest stimulatory effect on basal AC activity; the EC 50 value was 140 nM. In accordance with the literature (Engelhardt et al., 2001 ), this basal GTPdependent AC activity was reduced by the inverse agonist metoprolol. However, it should be emphasized that the inhibitory effect of metoprolol on GTP-stimulated AC activity did not reach statistical significance, indicating that the constitutive activity of the ␤ 1 -adrenoceptor at least in this system is small. The inhibitory effect of GTP Ͼ10 M on AC activity is due to competition of GTP with ATP at the catalytic site of AC (Gille et al., 2005) . The stimulatory effect of isoproterenol on AC in the absence of added GTP is explained by nucleoside diphosphokinase-mediated conversion of endogenous GDP to GTP by ATP (Kimura and Shimada, 1988) .
To identify GPCRs mediating stimulation (via G s ) or inhibition (via G i ) of AC in mouse heart, we examined several GPCR agonists in heart membranes (Fig. 7) . Histamine, serotonin, glucagon, and neuropeptide Y did not exhibit significant effects on AC activity. In contrast, the full ␤-adrenoceptor agonists epinephrine, norepinephrine, and isoproterenol increased AC activity approximately 2-fold, whereas dopamine showed partial ␤ 1 -adrenoceptor agonism. Partial agonism of dopamine has recently been reported for the recombinantly expressed ␤ 1 -adrenoceptor (Weitl and Seifert, 2008) . Because the histamine H 2 -receptor is known to stimulate AC in human heart (Fryer et al., 2006; Salazar et al., 2007) , we also examined the effects of the selective H 2 -receptor agonists dimaprit and impromidine (Dove et al., 2004) on AC activity in mouse heart membranes. However, impromidine and dimaprit (10 and 100 M each) did not exhibit a stimulatory effect on AC activity (data not shown).
Enzyme Kinetics of Mouse Heart AC and Recombinant AC5. Substrate saturation experiments under maximum stimulatory conditions were performed for mouse heart membranes and recombinant AC5. Note the different scales of the y-axes in Fig. 8, A and B , and the different scales of both the x-and y-axes in Fig. 8 , C and D. In the presence of Mg 2ϩ , AC5 and mouse heart AC exhibited similar K m and V max values (Fig. 8, A and B ; Table 4 ). Under Mn 2ϩ conditions, mouse heart AC showed 3-to 4-fold lower K m and V max values than recombinant AC5 (Fig. 8 , C and D; Table 5) .
Inhibitor Potencies at Mouse Heart AC and Recombinant AC Isoforms. MANT-nucleotides differentially inhibit AC isoforms (Gille et al., 2004) . We examined the inhibitory effects of eight MANT-nucleotides on mouse heart AC and recombinant ACs. In the presence of Mg 2ϩ , the rank order of inhibitory potency of MANT-nucleotides at mouse heart AC was MANT-ITP ϳ MANT-ITP␥S Ͼ MANT-GTP␥S Ͼ MANT-ATP␥S ϳ MANT-GTP Ͼ MANT-UTP Ͼ MANT-ATP Ͼ MANT-CTP (Table 4 ). The inhibitor profile of mouse heart AC was very similar to the inhibitor profile of AC5, with AC1 showing moderate and AC2 showing large differences relative to mouse heart AC (Table 4; Fig. 9A ). A correlation of the K i values of MANT-nucleotides on mouse heart AC and AC5 revealed a highly significant correlation with a slope close to 1.00, indicative for pharmacological identity between the two enzymes compared (Fig. 9B) . Note that this correlation concerns Mg 2ϩ conditions only. In the presence of Mn 2ϩ , the rank order of inhibitory potency of MANT-nucleotides at mouse heart AC was MANT- (Table 5) . Overall, inhibitory potencies of MANT-nucleotides were higher in the presence of Mn 2ϩ than in the presence of Mg 2ϩ , but the potency-enhancing effect of Mn 2ϩ ranged from just 3-fold for MANT-ITP␥S to ϳ100-fold for MANT-CTP and MANT-UTP. Differential effects of Mg 2ϩ and Mn 2ϩ on inhibitor potency of MANT-nucleotides were also observed for recombinant ACs (Gille et al., 2004) . The inhibitor profile of mouse heart AC in the presence of Mn 2ϩ was clearly different from the profile of AC2, but we also noted differences between mouse heart AC, on one hand, and ACs 1, 5, and 6, on the other hand. Specifically, in the presence of Mn 2ϩ , MANT-ITP␥S, MANT-GTP, MANT-GTP␥S, MANT-ATP, MANT-CTP, and MANT-UTP were all more potent inhibitors of mouse heart AC than of the ACs 1, 5, and 6. Thus, heart membranes may contain an AC isoform that under Mn 2ϩ conditions is more potently inhibited by several MANT-nucleotides than AC5. All inhibition curves with MANT-nucle- jpet.aspetjournals.org otides in heart membranes were monophasic (data not shown) so that we could not discriminate between various AC isoforms. In accordance with our previous study (Gille et al., 2004) , AC2 was less sensitive to inhibition by MANT-nucleotides than ACs 1, 5, and 6 (Table 5) . Unfortunately, the inhibitor profiles of ACs 1, 5, and 6 were very similar, allowing no differentiation between those three AC isoforms.
Discussion
The specific aim of this work was to characterize mouse heart AC, the very ambitious long-term aim being the development of novel drugs for the treatment of chronic heart failure, particularly AC5 inhibitors. To achieve the specific aim of our work, we performed real-time PCR for the detection of AC mRNA, immunoblots, and enzymological analysis of cardiac AC enzyme activity.
Real-Time PCR and Immunoblot Studies.
In real-time PCR experiments, we obtained evidence for the expression of ACs 1, 3 to 7, and 9 (Fig. 2) . The threshold values for detection of ACs 5 and 6 were lower than for the other AC isoforms, indicating that AC5 and AC6 are the most prominent AC isoforms on mRNA level in the heart. These findings are in agreement with the literature (Defer et al., 2000; Hanoune and Defer, 2001; Beazely and Watts, 2006) . There are reports on the expression of ACs1, 3, 4, and 7 in mammalian heart tissue (Manolopoulos et al., 1995; Ferrand et al., 1999; Defer et al., 2000; Sunahara and Taussig, 2002; Risøe et al., 2007) . Our findings are consistent with the literature. Unfortunately, the functional roles of ACs 1, 3, 4, and 7 in the heart are much more poorly understood than the roles of ACs 5 and 6. Furthermore, our data suggest that ACs 2 and 8 are not expressed in the heart. Despite numerous limitations of AC immunoblot analysis concerning antibody specificity and availability of recombinant ACs, positive immunoblot signals were obtained with the AC5/6 antibody in mouse heart membranes (Fig. 3B) . Therefore, our results from immunoblot analysis complement the results from RT-PCR experiments and indicate high expression of ACs 5 and 6 in the heart. GPCR Regulation of AC in Mouse Heart Membranes. Isoproterenol, GTP␥S, and FS effectively stimulated AC in mouse heart membranes, showing that the specific membrane preparation used in this work contained all components of the signaling cascade, i.e., ␤ 1 -adrenoceptors, G s proteins, and AC in a functionally intact form. G s -coupled histamine H 2 -receptors and glucagon receptors are expressed in mammalian heart as well (Méry et al., 1990; Matsuda et al., 2004; Fryer et al., 2006; Salazar et al., 2007) , but no modulation of murine cardiac AC activity was observed in this work using ligands for those GPCRs (Fig. 7) . The G i protein-coupled neuropeptide Y receptor subtypes Y 1 , Y 2 , and Y 5 are known to mediate functional responses in the heart as well (McDermott and Bell, 2007) , but no response was detected with neuropeptide Y. In addition, functional G s -coupled serotonin 5-hydroxytryptamine 4 -receptors are present in human ventricular myocardium (Levy et al., 2008) , but serotonin did not modulate cardiac AC activity. These findings suggest that in mouse heart, the ␤ 1 -adrenoceptor is the most important G s -coupled GPCR, and we have no positive evidence for a G i -coupled GPCR. In this study, we did not examine G q/11 -or G 12/13 -mediated signal transduc- Fig. 6 . Regulation of mouse heart membrane AC by isoproterenol, metoprolol, and GTP. Reaction mixtures contained 7 mM Mg 2ϩ , 40 M ATP, [␣-32 P]ATP (0.2-1.0 Ci/tube), 100 M cAMP, 0.4 mg/ml creatine kinase, 9 mM phosphocreatine, and 100 M IBMX. Reactions were carried out for 10 min at 30°C as described under Materials and Methods. A, reaction mixtures contained isoproterenol at the concentrations indicated on the abscissa and GTP (10 M). B, reaction mixtures contained GTP at the concentrations indicated on the abscissa and water (control), 10 M isoproterenol, or 10 M metoprolol. Data shown are means Ϯ S.D. of three independent experiments performed in duplicates. The statistical significance of the effect of metoprolol on AC activity versus control was assessed with the t test. However, the effect of metoprolol was not significant. tion pathways. The constitutive activity of the ␤ 1 -adrenoceptor was not significant in the native heart membranes ( Fig. 6 ) (Zhou et al., 2000; Engelhardt et al., 2001; . It cannot be excluded that other G s -coupled GPCRs than the ␤ 1 -adrenoceptor play a functional role in the heart. Specifically, our crude heart membrane preparation predominantly consists of cardiomyocytes, but other cell types such as fibroblasts, vascular smooth muscle cells, and endothelial cells contribute to the total cell mass, too. Thus, AC regulation by GPCRs in the latter three cell types may be below the detection limit of our global AC assay. We also cannot exclude the possibility that the membrane preparation destroyed the integrity of some signaling pathways.
Regulation of Mouse Heart AC by FS and FS Analogs. FS analogs differentially regulate ACs 1, 2, and 5 (Pinto et al., 2008) . The EC 50 values and relative maximum stimulatory effects of FS on heart AC and AC5 were similar, compatible with AC5 being the major cardiac AC isoform.
Moreover, BODIPY-FS was a partial agonist on heart AC and AC5, whereas on AC2, BODIPY-FS was an inverse agonist. These data indicate that compared with AC5, AC2 is not of functional relevance in the heart, a conclusion in agreement with the real-time PCR experiments. Considering the low basal AC activity in mouse heart membranes and the very robust stimulation by FS as well as AC9 being FS-insensitive (Yan et al., 1998) , the contribution of AC9 to the AC activity in heart membranes seems to be of minor importance, too. Intriguingly, the correlations of potencies and particularly efficacies of FS analogs on heart AC and AC5 obtained in the presence of Mn 2ϩ indicate that AC5 is not the only active AC isoform in heart membranes.
Differential Regulation of Mouse Heart AC by Divalent Cations. Mg 2ϩ is the physiological cation for AC activation in vivo. However, because with the nonphysiological cation Mn 2ϩ the inhibitor potencies are higher than in the presence of Mg 2ϩ , the former cation is often used in in vitro AC activities were determined as described under Materials and Methods. K m and V max values were obtained by nonlinear regression analysis of substrate-saturation experiments and are the means Ϯ S.D. of three to four independent experiments performed in duplicates. The K i values for MANT-ITP, MANT-ATP␥S, MANT-CTP, and MANT-UTP on AC1, AC2, and AC5 were determined in this work as described by Gille et al. (2004) and represent the means of at least three independent experiments. K i values on cardiac AC were determined in this work as described under Materials and Methods and are the means of at least three independent experiments performed in duplicates. Standard deviations were generally smaller than 20% of the means. Inhibition curves were analyzed by nonlinear regression. (Gille et al., 2004 (Gille et al., , 2005 Taha et al., 2009 ). For comparison with previous studies, we conducted some AC studies with heart membranes both in the presence of Mg 2ϩ and Mn 2ϩ . Regarding the effects of FS on AC, the exchange of Mg 2ϩ against Mn 2ϩ had little effect on potencies and relative maximum stimulatory effects on heart AC and recombinant ACs 1, 2, and 5 (Pinto et al., 2008) . However, as expected, MANT-nucleotides inhibited heart membrane more potently in the presence of Mn 2ϩ than in the presence of Mg 2ϩ . With Mg 2ϩ as physiological divalent cation, recombinant AC5 and mouse heart AC showed similar K m and V max values, supporting the notion that AC5 is an important AC isoform in mouse heart in vivo. However, under Mn 2ϩ conditions, AC5 showed a 4-fold higher K m value than cardiac AC, and the V max value of AC5 was 3-fold higher than that of heart membranes. It is possible that under physiologically relevant Mg 2ϩ conditions, predominantly AC5 is activated in heart membranes, whereas under nonphysiological Mn 2ϩ conditions, other AC isoforms than AC5 are activated as well, masking, at least partially, AC5. This interpretation is supported by the finding that under Mg 2ϩ conditions, the inhibitory profiles of MANT-nucleotides on mouse heart AC and AC5 were very similar, whereas in the presence of Mn 2ϩ , substantial differences between these ACs were noted. Under Mn 2ϩ conditions, the kinetics of mouse heart AC and the inhibitory profile of MANT-nucleotides on mouse heart AC do also not match the profiles of ACs 1, 2, and 6. Moreover, the correlations of the potencies and efficacies of FS analogs between mouse heart AC and AC5 in the presence of Mn 2ϩ point to nonidentity of the enzymes studied. These data indicate that under Mn 2ϩ conditions, the relative contribution of AC5 to the total AC activity in mouse heart membranes is smaller than in the presence of Mg 2ϩ . The elusive Mn 2ϩ -activated mouse heart AC isoform is more sensitive to inhibition by most MANT-nucleotides than recombinant AC5.
A further limitation of our study concerns the lack of pharmacological and immunological discrimination between ACs 5 and 6, both of which are functionally important in the heart (Okumura et al., 2003; Takahashi et al., 2006) . To learn more on the functional properties of AC5 in a native membrane environment, it will be important to examine tissues that are highly enriched in AC5 relative to other tissues. The striatum may represent such a tissue (Glatt and Snyder, 1993) . However, analysis of striatal membranes is beyond the scope of this study.
Conclusions. The real-time PCR experiments, immunoblot studies and enzyme kinetics, MANT-nucleotide inhibition experiments, FS stimulation experiments as well as our previous electrophysiological studies (Rottlaender et al., 2007) indicate that AC5 is an important cardiac AC isoform, provided Mg 2ϩ conditions are considered. To the best of our knowledge, MANT-ITP is the most potent competitive AC5 and cardiac AC inhibitor reported so far. Thus, hypoxanthine nucleotides provide an excellent starting point for the future   TABLE 5 Kinetic properties of mouse heart AC and ACs 1, 2, 5, and 6 and potencies of MANT-nucleotides at ACs in the presence of Mn 2ϩ AC activities were determined as described under Materials and Methods. K m and V max values were obtained by nonlinear regression analysis of substrate-saturation experiments and are the means Ϯ S.D. of three to four independent experiments performed in duplicates. The K i values for MANT-ITP, MANT-ATP␥S, MANT-CTP, and MANT-UTP on AC1, AC2, AC5, and AC6 were determined in this work as described by Gille et al. (2004) and represent the means of at least three independent experiments. K i values on cardiac AC were determined in this work as described under Materials and Methods and are the means of at least three independent experiments performed in duplicates. Standard deviations were generally smaller than 20% of the means. Inhibition curves were analyzed by nonlinear regression using the Prism 4.02 software (GraphPad Software Inc. a Values were taken from Gille et al. (2004) . Fig. 9 . Comparison of the inhibitory potencies of MANT-nucleotides on mouse heart membrane AC and recombinant AC isoforms expressed in Sf9 cells in the presence of Mg 2ϩ . A, K i values of MANT-nucleotides on mouse heart membrane AC and ACs 1, 2, and 5 shown in Table 4 were plotted. B, correlation of the K i values of MANT-nucleotides on mouse heart AC versus AC5. Data were analyzed by linear regression. Dashed lines represent 95% confidence intervals of the linear regression lines. Slope, 1.033 Ϯ 0.065; r 2 , 0.9768; p Ͻ 0.0001.
1164
Gö ttle et al.
at ASPET Journals on December 31, 2017 jpet.aspetjournals.org development of AC5 inhibitors. However, a major as yet unresolved issue is that immunologically and pharmacologically, ACs 5 and 6 are difficult to discriminate, although at the organ level they have different functions (Okumura et al., 2003; Takahashi et al., 2006) . Moreover, Mn 2ϩ reduces the contribution of AC5 to overall AC activity in heart membranes and unmasks an elusive AC isoform. Thus, future AC studies in native membranes should be preferably conducted in the presence of Mg 2ϩ although Mn 2ϩ is very popular in AC studies.
With respect to in vivo application, AC5 inhibitors with stability against enzymatic degradation are required. By analogy to antiviral drugs, lipophilic nucleotide prodrugs with high bioavailability have to be designed. Conversion of the nucleotide prodrug to the active nucleoside 5Ј-triphosphate by phosphorylation is then accomplished by specific kinases (Laux et al., 2004) . It is noteworthy that MANTNTPs and the corresponding MANT-NTP␥Ss possess comparable potencies on heart AC. The advantage of MANTNTP␥Ss relative to MANT-NTPs is that phosphorothioates are resistant to phosphatases (Eckstein, 1985) , rendering them valuable experimental tools for electrophysiological studies in which nucleotides diffuse into the cytosol via the patch pipette (Rottlaender et al., 2007) .
